| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 1.401 | 1.140 | 1.771 | 1.754 | 510 | 132 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 1.401 | 1.140 | 1.771 | 1.754 | 510 | 132 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 170 | 977 | 806 | 422 | 761 | 593 | 0 | 0 | 0 | 1.005 |
| Gross Profit/Loss - EUR | 1.231 | 163 | 965 | 1.332 | -251 | -461 | 0 | 0 | 0 | -1.005 |
| Net Profit/Loss - EUR | 1.189 | 128 | 912 | 1.287 | -267 | -465 | 0 | 0 | 0 | -1.005 |
| Employees | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Cabinet Medical Dr. Jidovin Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.379 | 537 | 0 | 9.756 | 9.567 | 9.386 | 9.178 | 9.206 | 9.178 | 8.122 |
| Current Assets | 2.171 | 3.107 | 4.496 | 5.573 | 5.252 | 4.596 | 4.469 | 4.483 | 4.469 | 4.444 |
| Inventories | 26 | 81 | 0 | 115 | 113 | 111 | 108 | 108 | 108 | 108 |
| Receivables | 1 | 1 | 1 | 2 | 1 | 1 | 10 | 10 | 10 | 10 |
| Cash | 2.144 | 3.025 | 4.495 | 5.457 | 5.138 | 4.484 | 4.351 | 4.364 | 4.351 | 4.327 |
| Shareholders Funds | 3.541 | 3.633 | 4.484 | 5.689 | 5.312 | 4.746 | 4.641 | 4.655 | 4.641 | 3.610 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 0 |
| Debts | 9 | 10 | 12 | 9.640 | 9.507 | 9.235 | 9.006 | 9.034 | 9.006 | 8.956 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Cabinet Medical Dr. Jidovin Srl